SciClone’s Meropenem-Vaborbactam Wins GBA Approval as First Antibiotic Under Medical Connect
SciClone Pharmaceuticals Inc. announced that Meropenem/Vaborbactam for Injection has been approved under the “Hong Kong-Macau...
Greater Bay Area
CTTQ Deepens Partnership with Shionogi to Accelerate Naldemedine Launch in China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ), a core subsidiary of Sino Biopharmaceutical Limited...
Jenscare Secures LuX‑Valve Approval for Transjugular Tricuspid Replacement in Greater Bay Area
Jenscare Scientific Co., Ltd (HKG: 9877) announced that its LuX‑Valve Plus transjugular tricuspid valve replacement...
Guangdong Launches 5‑Year Plan to Streamline Import of Urgently Needed Drugs and Medical Devices
The Guangdong Provincial Drug Administration and the Guangdong Provincial Health Commission jointly announced the “Administrative...
Macao Drug Administration Expands White List for Designated Medical Institutions in Cooperation Zone
The Drug Administration of the Macao Special Administrative Region (SAR) of China has announced the...
Santen’s Tapcom Administered to First Patient in GBA via Drug Access Policy
Japan-based Santen Pharmaceutical Co., Ltd. announced that its novel glaucoma treatment, Tapcom (tafluprost/timolol maleate), has...
Pfizer Partners with HSITP to Boost Life Sciences Innovation in Greater Bay Area
US giant Pfizer Inc. (NYSE: PFE) has entered into a partnership with Hong Kong-Shenzhen Innovation...
QuantumPharm and Hengjian Launch GBA AI+ Innovation Consortium
Shenzhen-based QuantumPharm Inc. (HKG: 2228), also known as Xtalpi Inc., and Guangdong Hengjian Investment Holding...
Boehringer Ingelheim-SEC Joint Incubator Launches in Shenzhen’s Luohu District
On December 23, the Boehringer Ingelheim-SEC Joint innovative incubator was inaugurated in Luohu District, Shenzhen....
Guangdong Province Releases List of Urgent Clinical Drugs and Devices for GBA Cities
The medical products administration and health commission of Guangdong province have released a list of...
Medtronic Partners with China Resources Guangdong Pharmaceutical at CIIE for Medical Equipment Development
US-Irish firm Medtronic (NYSE: MDT) has entered into a partnership with China-based China Resources Guangdong...
Everest Medicines’ Velsipity Approved for Use in Select Hospitals in China’s Greater Bay Area
Everest Medicines (HKG: 1952), a China-based pharmaceutical company, has announced that it has received approval...
Lundbeck’s Vyepti Migraine Treatment Available at Sun Yat-sen Memorial Hospital Through Greater Bay Area Policy
Vyepti (eptinezumab), a migraine treatment developed by Denmark-based biopharmaceutical company H. Lundbeck A/S (OTCMKTS: HLBBF),...
AstraZeneca’s Saphnelo Approved for Use in Guangdong Under ‘Hong Kong-Macau Drug Access’ Policy
AstraZeneca (AZ, NASDAQ: AZN), a leading UK pharmaceutical company, has announced that its drug Saphnelo...
Merck KGaA’s Pergoveris Treatment Expands Access to Advanced Reproductive Care in Greater Bay Area
Merck KGaA (MRK, NYSE: MRK) , a leading science and technology company based in Germany,...
AstraZeneca’s Strensiq Approved for Rare Disease Therapy under Greater Bay Area’s Drug Access Policy
AstraZeneca (NASDAQ: AZN, LON: AZN) , a leading UK pharmaceutical company, has received approval for...
AstraZeneca’s Strensiq Gains Approval for Rare Disease Therapy in Guangdong Under “Hong Kong-Macau Drug and Device Access”
LONDON—AstraZeneca (NASDAQ: AZN, LON: AZN) , a leading UK-based pharmaceutical company, has announced that its...
CNBG and University of Macau Ink Deal to Establish Joint Biotech Lab
China National Biotec Group Company Ltd (CNBG) has announced a strategic collaboration with the University...
Luye Pharma Group Secures RMB 1.6 Billion Investment to Boost Financials and R&D
Luye Pharma Group (HKG: 2186), a leading pharmaceutical company based in China, has announced that...
Novartis’s Tabrecta Earns NMPA Nod for MET-Positive Advanced NSCLC in China
Swiss pharmaceutical titan Novartis has secured marketing approval from China’s National Medical Products Administration (NMPA)...